Mapping the feline cancer genome opens new frontiers for human cancer treatment
Indeed, a recent study published in Science shows that feline tumours share key mutations, driver genes and biological mechanisms with human ones
For the first time, the feline cancer genome has been mapped and closely resembles that of humans. The study helps in the understanding of breast cancer and skin cancer and in the development of therapies for both species.
Bob, the stray cat who became a symbol of rebirth in James Bowen's autobiographical bestseller, had already 'saved' a life. Now his fellow cats could help save many more. A recent study published in Science shows that feline tumours share key mutations, driver genes and biological mechanisms with human ones.
It is the first large-scale map of the cancer genome in the domestic cat, and indicates that felines can become valuable allies in accelerating cancer research, paving the way for clinical trials conducted in parallel on the two species. The speed at which feline tumours develop, which is much faster than in humans, would be exploited to test new drugs and protocols more quickly.
The study and the 'great guardian' gene
"One of the greatest developments ever recorded in feline oncology," called the study's senior author, Louise van der Weyden of the Wellcome Sanger Institute in Cambridge, leading an international team that involved the Ontario Veterinary College, the University of Bern and the Cornell University College of Veterinary Medicine in New York State.
The team analysed 493 tumour tissue samples from cats in five countries, covering 13 different types of neoplasia.
-U205598524LrD--1020x533@IlSole24Ore-Web.jpeg?r=650x341)

